NCT03850626View on ClinicalTrials.gov

Validation of Combined Symptom Medication Score (cSMS) in Allergic Patients

CompletedOBSERVATIONAL

Enrollment

168

Participants

Timeline

Start Date

September 9, 2018

Primary Completion Date

September 3, 2020

Study Completion Date

September 3, 2020

Conditions

Allergic RhinoconjunctivitisAllergic Asthma

Interventions

BIOLOGICAL

Immunotherapy

subcutaneous injection

Trial Locations (1)

76869

Dr. med Andrea Kienle-Gogolok, Bad Schönborn

Sponsors

Lead Sponsor

Leti Pharma GmbH

All Listed Sponsors

lead

Leti Pharma GmbH

INDUSTRY

NCT03850626 - Validation of Combined Symptom Medication Score (cSMS) in Allergic Patients | Biotech Hunter | Biotech Hunter